Invasive Fetal Medicine Procedures — Amniocentesis and CVS
In short
Fetal medicine procedures fall into two groups. Diagnostic sampling — CVS and amniocentesis — answers a genetic question definitively and carries a small procedure risk. Therapeutic procedures treat a problem already identified. Neither is routine: each is offered only when a specific finding makes the information worth the risk. Fetal sex is neither determined nor disclosed, as per the PC-PNDT Act.
Invasive prenatal procedures — amniocentesis and chorionic villus sampling — are used when screening findings or family history make genetic diagnosis necessary. The decision to proceed is shared between the patient and the clinician after thorough counselling about the probability of finding a condition, the procedural risk (small but real), and the implications of the result. These are not routine procedures; they are reserved for situations where the genetic information will materially change pregnancy decisions.
Our approach to invasive procedures
Every patient considering an invasive procedure receives structured pre-procedure counselling: indications, what the result will and won’t tell, procedural technique, miscarriage risk (current data suggests below 0.5% in experienced hands), and what happens if a positive result is found. The procedure itself is performed under ultrasound guidance with continuous monitoring; recovery is typically uncomplicated.
Amniocentesis
Performed from around 15 weeks. A small volume of amniotic fluid is sampled transabdominally under ultrasound guidance. Fetal cells in the fluid undergo karyotyping or specific genetic testing. Used for diagnostic confirmation after positive screening, advanced maternal age combined with anxiety about uncertainty, or specific family-history indications.
Chorionic Villus Sampling (CVS)
Performed from 11 weeks. Placental tissue is sampled transabdominally or transcervically under ultrasound guidance. Allows earlier diagnostic information than amniocentesis. Used where early diagnosis materially affects decision-making.
When an invasive test is offered
- A higher-chance result on first-trimester combined screening or NIPT. A screening result gives a probability, not a diagnosis, so it should be confirmed before any major decision.
- A nuchal translucency of 3.5 mm or more, or a structural difference found on a scan.
- A previous pregnancy affected by a chromosomal condition.
- A parent who carries a balanced chromosomal rearrangement.
- A known single-gene condition in the family, such as thalassaemia, spinal muscular atrophy or sickle cell disease.
The decision rests on the question the test can answer for you, discussed with you, rather than on age alone.
Results, and how long they take
A rapid test (QF-PCR or FISH) for the commonest chromosome conditions usually reports in 2–3 days. A full karyotype or a chromosomal microarray takes about 2–3 weeks; microarray is recommended when a structural difference has been seen on the scan, because it finds smaller changes that a karyotype can miss. Testing for a specific single-gene condition is arranged for your family’s indication. Results are explained in a conversation, with time to think before any decision.
Risks, in context
With an experienced operator, the extra chance of miscarriage caused by amniocentesis or CVS is small, probably below 0.5% [Source: RCOG Green-top Guideline No. 8, 2021]. Infection is rare. If your blood group is RhD-negative, you are offered anti-D afterwards.
Fetal blood sampling (cordocentesis), used in selected cases after about 18–20 weeks, for example to assess suspected fetal anaemia, carries a higher risk and is used only when amniocentesis cannot answer the question.
Before any procedure: counselling
Every invasive test is preceded by counselling that covers: why the test is being offered, and whether it can answer your question; the alternatives, including not testing; the risks; what results will and will not show, and when; and the options if a result is abnormal, presented without direction. Written consent follows, with time to reflect, and you can decline at any stage without any effect on your care.
Post-procedure care
Patients receive structured post-procedure information (warning symptoms, when to call), and we contact each patient personally with results. The conversation about a result — whether reassuring or otherwise — is unhurried.
Procedures covered
Amniocentesis in Ahmedabad — Prenatal Genetic Diagnosis
Explore →Chorionic Villus Sampling (CVS) in Ahmedabad
Explore →Frequently asked questions
Is amniocentesis painful?
Most women feel brief pressure or a sharp sensation as the needle goes in; the sampling itself takes a few minutes. Local anaesthetic can be used for the skin.
What is the difference between NIPT and amniocentesis?
NIPT is a blood test that screens for the common chromosome conditions using fragments of placental DNA in the mother’s blood; it gives a probability, not a diagnosis. Amniocentesis tests the baby’s own cells and gives a definite answer. A high-chance NIPT result should be confirmed by CVS or amniocentesis before any decision.
Can a normal result miss a condition?
Yes. A karyotype finds large chromosome changes and microarray finds smaller ones, but neither tests for single-gene conditions unless specifically requested, and no test can rule out every condition.
What happens if the result is abnormal?
The result is explained in person, with time and support. All options are discussed without direction, and the decision remains yours and your partner’s.
Guidelines we follow
- ISUOG practice guidelines on invasive prenatal procedures
- RCOG green-top guideline on amniocentesis and CVS
- FMF training standards for invasive procedures
Where this fits
Invasive procedures typically follow positive findings from screening or scans. Results inform decisions about specific conditions.
For a specialist fetal medicine consultation, contact Balaji Horizon Women’s Hospital.
WhatsApp the hospital · +91 97234 31544 · Science City Road, Ahmedabad 380060
CVS (10-13 weeks) and amniocentesis (15+ weeks) procedure-related miscarriage rates are approximately 0.1-0.3% when performed by experienced operators. Counselling should cover timing, accuracy, and recovery.
CONTINUE READING
Explore the Fetal Medicine Programme
Invasive Fetal Medicine Procedures is part of the broader fetal medicine programme. The main fetal medicine pillar covers the complete pregnancy ultrasound schedule.
Fetal-medicine procedures — precise answers, carefully counselled
When screening raises a question, a fetal-medicine procedure can give a definitive answer. The procedures in this area — chorionic villus sampling, amniocentesis and related interventions — are offered for a specific indication, never routinely, and always with full counselling about what each can tell you and its small risks.
Our principles
We perform these only when the information will genuinely change your care, under continuous ultrasound guidance by experienced hands, with honest discussion of the procedure-related risk beforehand. Where a non-invasive test can answer the question, we choose it first.
Explore the individual procedures for what each involves, when it is appropriate, and the alternatives — and we will always help you decide what is right for your pregnancy rather than presenting tests as a formality.
Dr. Priyadatt Patel
Senior Gynecologist · Advanced Laparoscopic Surgeon · IVF and Endometriosis Programme Lead
MS OBGyn · Pregnancy Care · Advanced Gynaecological Ultrasound · Fertility Preservation
ESHRE / ESGE / AAGL / ASRM guideline-aligned practice. 3D Karl Storz precision technique. Fertility-preservation-first philosophy. Evidence-based decisions, honest counselling, long-term outcomes orientation.
323, Satyamev Eminence, Beside Saptak Bungalows & AUDA Water Tank, Science City Road, Sola, Ahmedabad 380060
Open 24 hours (emergencies & labour) · OPD Mon–Sat 11:00–20:00 · +91 97234 31544
Naranpura, Ahmedabad
Mon–Sat 08:30–10:30 · +91 70460 02566
